ATLASBioMarin Pharmaceutical (BMRN) Q3 2026 earnings results
BioMarin Pharmaceutical (BMRN) reported EPS of -$0.08 against an analyst estimate of -$0.30: a beat of $0.22 (73.3%). The quarter ended Sep 30, 2026; the company reported on Monday, November 2, 2026, after the close.
Status: Confirmed · 15:55 ET, Nov 2 · Source: EODHD (calendar and fundamentals, cross-checked)
Notify me when BioMarin Pharmaceutical reports
Track BMRN free Add BioMarin Pharmaceutical to a free ATLAS watchlist.
BMRN Q3 2026 results at a glance
| EPS reported | -$0.08 |
|---|---|
| EPS estimate | -$0.30 |
| Surprise | Beat · +$0.22 (+73.3%) |
| Quarter ended | Sep 30, 2026 |
| Reported | Nov 2, 2026, after the close |
| Status | Confirmed · 15:55 ET, Nov 2 |
EPS is as supplied by EODHD, in US dollars per share; whether it is adjusted or GAAP follows that source. This is BioMarin Pharmaceutical’s Q3 2026, a calendar-year company.
BioMarin Pharmaceutical EPS surprise history: last 3 quarters
BioMarin Pharmaceutical beat the EPS estimate in 3 of its last 3 reports, with an average surprise of +41.3%.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Nov 2, 2026 | -$0.30 | -$0.08 | +73.3% | Beat | – |
| Aug 6, 2026 | $0.95 | $1.20 | +26.3% | Beat | +6.5% |
| May 29, 2026 | $0.74 | $0.92 | +24.3% | Beat | +4.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it. It is filled in a few trading days after each report.
BMRN stock reaction to the report
The price reaction will be added after the Nov 3, 2026 close.
This section appears once a post-report closing price exists and updates with every new close.
Next BMRN earnings report
BioMarin Pharmaceutical has not announced its next earnings date yet. This page shows a date only once it is confirmed. See the BMRN earnings calendar.
ATLAS fair value and signal for BMRN
| Last price | $58.06 (-0.8%) |
|---|---|
| Chance of a higher close in 1 month | 51% (normal range $55.33–$61.20) |
These are model outputs from the same valuation and calibrated model as the BioMarin Pharmaceutical stock page. They describe an ordinary period and are not a forecast of any particular outcome.
BioMarin Pharmaceutical Q3 2026 earnings: frequently asked questions
Did BioMarin Pharmaceutical beat earnings estimates for Q3 2026?
BioMarin Pharmaceutical reported EPS of -$0.08 against an analyst estimate of -$0.30: a beat of $0.22 (73.3%).
When did BioMarin Pharmaceutical report Q3 2026 results?
BioMarin Pharmaceutical reported on Monday, November 2, 2026, after the close, for the quarter ended Wednesday, September 30, 2026.
How often does BMRN beat EPS estimates?
In its last 3 reports with a recorded result, BioMarin Pharmaceutical beat the EPS estimate 3 times; the average surprise was +41.3%. Past results do not predict the next one.
How does ATLAS confirm a result?
A result is published only after it is cross-checked: the EODHD earnings calendar and the EODHD fundamentals feed must show the same EPS for the same fiscal period, or the same value must appear in two consecutive checks. Unconfirmed figures are never published. If the figures are revised later, this page updates.
Educational information, not investment advice. Disclaimer